The wire › SEC Form 8-K
Aprea Therapeutics, Inc. APRE
Filed with the SEC on Jan 23, 2026. Reported event date Jan 23, 2026.
- Business address
- Doylestown, PA
- State
- Pennsylvania
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1781983
- Accession number
- 0001104659-26-006267
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing